Banning Lasix in 2-year Old Thoroughbred Horses and Graded Thoroughbred Stakes Races; Administrative Policy SHRC 2021-2
[51 Pa.B. 2921]
[Saturday, May 22, 2021]
The State Horse Racing Commission (Commission), in accordance with 3 Pa.C.S. § 9312(6) (relating to additional powers of commission) of the Race Horse Industry Reform Act and 7 Pa. Code § 401.4(a) (relating to substances of therapeutic value), is authorized to adopt National standards relating to prohibited substances, uniform drug threshold levels or penalties and to regulate substances of therapeutic value, including the use of Furosemide (Lasix) in race horses.
The Commission recognizes that Lasix is helpful in the management of Exercise Induced Pulmonary Hemorrhage. In overseeing the race-day use of Lasix, the Commission has placed strict regulatory controls on the dose, route and time the medication is administered. These measures are designed to provide a complete regulation of Lasix and to prevent the misuse of the drug, including, where appropriate, the reasonable restriction on the use of Lasix.
On April 27, 2021, the Commission approved the above policy which provides notice that it intends to follow the National racing standard by expressly banning the use of Lasix in 2-year-old thoroughbred horses racing in thoroughbred racetracks in this Commonwealth and banning the use of Lasix in Graded Stakes Races conducted in this Commonwealth effective June 1, 2021.
The Commission's specific administrative policy has been posted and published on the Commission's web site at http://www.agriculture.pa.gov/Animals/RacingCommission/commission/Pages/Publications.aspx.
THOMAS F. CHUCKAS, Jr.,
Bureau of Thoroughbred Horse Racing
[Pa.B. Doc. No. 21-834. Filed for public inspection May 21, 2021, 9:00 a.m.]
No part of the information on this site may be reproduced for profit or sold for profit.